|
| Cyr61/CCN1 targets for chemosensitization in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.26986
Snigdha Banerjee, Arnab Ghosh, Daniel D. VonHoff, Sushanta K. Banerjee
|
| 3579-3580 |
|
| Elevated telomere dysfunction in cells containing the African-centric Pro47Ser cancer-risk variant of TP53 |
|
https://doi.org/10.18632/oncotarget.26980
Stephen Tutton, Zhong Deng, Nitish Gulve, Olga Vladimirova, Kate Beishline, Andreas Wiedmer, Maureen Murphy, Paul M. Lieberman
|
| 3581-3591 |
|
| Flow based single cell analysis of the immune landscape distinguishes Barrett’s esophagus from adjacent normal tissue |
|
https://doi.org/10.18632/oncotarget.26911
Moen Sen, Friedrich Hahn, Taylor A. Black, Maureen DeMarshall, Warren Porter, Eileen Snowden, Stephanie S. Yee, Frances Tong, Mitchell Ferguson, Emylee N. Fleshman, Hiroshi Nakagawa, Gary W. Falk, Gregory G. Ginsberg, Michael L. Kochman, Rainer Blaesius, Anil K. Rustgi, Erica L. Carpenter
|
| 3592-3604 |
|
| Prognostic significance of the pretreatment prognostic nutritional index in patients with epithelial ovarian cancer |
|
https://doi.org/10.18632/oncotarget.26914
Naoko Komura, Seiji Mabuchi, Eriko Yokoi, Kotaro Shimura, Mahiru Kawano, Yuri Matsumoto, Tadashi Kimura
|
| 3605-3613 |
|
| Molecular characterization of carcinosarcomas arising in the uterus and ovaries |
|
https://doi.org/10.18632/oncotarget.26942
Marta Brunetti, Antonio Agostini, Julie Staurseth, Ben Davidson, Sverre Heim, Francesca Micci
|
| 3614-3624 |
|
| A three-step approach identifies novel shear stress-sensitive endothelial microRNAs involved in vasculoprotective effects of high-intensity interval training (HIIT) |
|
https://doi.org/10.18632/oncotarget.26944
Boris Schmitz, Franziska L. Breulmann, Bothaynah Jubran, Florian Rolfes, Lothar Thorwesten, Michael Krüger, Andreas Klose, Hans-Joachim Schnittler, Stefan-Martin Brand
|
| 3625-3640 |
|
| Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes |
|
https://doi.org/10.18632/oncotarget.26950
Nadin D. Exner, Jaime Alberto Campos Valenzuela, Khalil Abou-El-Ardat, Hrvoje Miletic, Peter C. Huszthy, Petra M. Radehaus, Evelin Schröck, Rolf Bjerkvig, Lars Kaderali, Barbara Klink, Janice M. Nigro
|
| 3641-3653 |
|
| Development, validation, and comparison of gene analysis methods for detecting EGFR mutation from non-small cell lung cancer patients-derived circulating free DNA |
|
https://doi.org/10.18632/oncotarget.26951
Masaki Hanibuchi, Akira Kanoh, Takuya Kuramoto, Tatsuro Saito, Makoto Tobiume, Atsuro Saijo, Hiroyuki Kozai, Mayo Kondo, Shun Morizumi, Hiroto Yoneda, Kozo Kagawa, Hirokazu Ogino, Seidai Sato, Hiroshi Kawano, Kenji Otsuka, Yuko Toyoda, Hiroshi Nokihara, Hisatsugu Goto, Yasuhiko Nishioka
|
| 3654-3666 |
|
| PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.26960
Sandeep Rajput, Zhanfang Guo, Shunqiang Li, Cynthia X. Ma
|
| 3667-3680 |
|
| Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential |
|
https://doi.org/10.18632/oncotarget.26978
Balraj Singh, Vanessa N. Sarli, Hannah E. Kinne, Anna Shamsnia, Anthony Lucci
|
| 3681-3693 |
|
| Cancer-testis antigens MAGEA proteins are incorporated into extracellular vesicles released by cells |
|
https://doi.org/10.18632/oncotarget.26979
Anneli Kuldkepp, Magda Karakai, Eve Toomsoo, Olavi Reinsalu, Reet Kurg
|
| 3694-3708 |
|
| Functional interplay between YY1 and CARM1 promotes oral carcinogenesis |
|
https://doi.org/10.18632/oncotarget.26984
Amit K. Behera, Manoj Kumar, Muthu K. Shanmugam, Aditya Bhattacharya, Vinay J. Rao, Akshay Bhat, Madavan Vasudevan, Kodaganur S. Gopinath, Azeem Mohiyuddin, Anupam Chatterjee, Gautam Sethi, Tapas K. Kundu
|
| 3709-3724 |
|
| 1,4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours |
|
https://doi.org/10.18632/oncotarget.26966
Clare T. Butler, Susan A. Kennedy, Amy Buckley, Ronan Doyle, Emer Conroy, William M. Gallagher, Jacintha O’Sullivan, Breandán N. Kennedy
|
| 3725-3744 |
|
| Dissecting the role of RNA modification regulatory proteins in melanoma |
|
https://doi.org/10.18632/oncotarget.26959
Parmanand Malvi, Biao Wang, Shreni Shah, Romi Gupta
|
| 3745-3759 |
|
| Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification |
|
https://doi.org/10.18632/oncotarget.26940
Shan-Ju Yeh, Chien-An Chang, Cheng-Wei Li, Lily Hui-Ching Wang, Bor-Sen Chen
|
| 3760-3806 |
|
| Association study of apelinAPJ system genetic polymorphisms with incident metabolic syndrome in a Chinese population: a casecontrol study |
|
https://doi.org/10.18632/oncotarget.24111
|
| 3807-3817 |
|
| Regression of BRAFV600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases |
|
https://doi.org/10.18632/oncotarget.26932
Peter Y.M. Woo, Tai-Chung Lam, Jenny K.S. Pu, Lai-Fung Li, Roland C.Y. Leung, Jason M.K. Ho, James T.F. Zhung, Belinda Wong, Timonthy S.K. Chan, Herbert H.F. Loong, Ho-Keung Ng
|
| 3818-3826 |
|
| Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL |
|
https://doi.org/10.18632/oncotarget.27011
John C. Byrd, Stephen Smith, Nina Wagner-Johnston, Jeff Sharman, Andy I. Chen, Ranjana Advani, Bradley Augustson, Paula Marlton, S. Renee Commerford, Kwame Okrah, Lichuan Liu, Elaine Murray, Elicia Penuel, Ashley F. Ward, Ian W. Flinn
|
| 3827-3830 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
